Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Burke

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Robotic Surgery|June 3, 2022
The current status of robotic colorectal surgery training programmesDeena Harji, Fergus Houston, Joshua Burke, et al.
Journal of Endometriosis and Pelvic Pain Disorders|October 16, 2018
Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled StudyBruce Carr, Linda Giudice, W Paul Dmowski, et al.
The Journal of Clinical Psychiatry|November 16, 2017
The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension StudyStewart A Factor, Gary Remington, Cynthia L Comella, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|July 26, 2013
Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled studyMichael P Diamond, Bruce Carr, W Paul Dmowski, et al.
Journal of Medical Internet Research|February 19, 2025
Identifying Research Priorities in Digital Education for Health Care: Umbrella Review and Modified Delphi Method StudyAlison Potter, Chris Munsch, Elaine Watson, et al.
The American Journal of Psychiatry|March 22, 2017
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive DyskinesiaRobert A Hauser, Stewart A Factor, Stephen R Marder, et al.
Journal of Clinical Psychopharmacology|November 6, 2019
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive DyskinesiaStephen R Marder, Carlos Singer, Jean-Pierre Lindenmayer, et al.
BMJ Innovations|August 9, 2023
Virtual hackathon to tackle COVID-19 unmet needsWilliam S Bolton, Shu Ng, Angela Lam, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Robotic Surgery|June 3, 2022
The current status of robotic colorectal surgery training programmesDeena Harji, Fergus Houston, Joshua Burke, et al.
Journal of Endometriosis and Pelvic Pain Disorders|October 16, 2018
Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled StudyBruce Carr, Linda Giudice, W Paul Dmowski, et al.
The Journal of Clinical Psychiatry|November 16, 2017
The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension StudyStewart A Factor, Gary Remington, Cynthia L Comella, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|July 26, 2013
Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled studyMichael P Diamond, Bruce Carr, W Paul Dmowski, et al.
Journal of Medical Internet Research|February 19, 2025
Identifying Research Priorities in Digital Education for Health Care: Umbrella Review and Modified Delphi Method StudyAlison Potter, Chris Munsch, Elaine Watson, et al.
The American Journal of Psychiatry|March 22, 2017
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive DyskinesiaRobert A Hauser, Stewart A Factor, Stephen R Marder, et al.
Journal of Clinical Psychopharmacology|November 6, 2019
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive DyskinesiaStephen R Marder, Carlos Singer, Jean-Pierre Lindenmayer, et al.
BMJ Innovations|August 9, 2023
Virtual hackathon to tackle COVID-19 unmet needsWilliam S Bolton, Shu Ng, Angela Lam, et al.
Pageof 3